- Home
- PED vs BRNS Comparison
PED vs BRNS Comparison
Compare PED & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- BRNS
- Stock Information
- Founded
- PED N/A
- BRNS 2016
- Country
- PED United States
- BRNS United Kingdom
- Employees
- PED N/A
- BRNS N/A
- Industry
- PED Oil & Gas Production
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- BRNS Health Care
- Exchange
- PED Nasdaq
- BRNS Nasdaq
- Market Cap
- PED 52.8M
- BRNS 55.9M
- IPO Year
- PED N/A
- BRNS 2021
- Fundamental
- Price
- PED $0.59
- BRNS $1.29
- Analyst Decision
- PED Strong Buy
- BRNS Strong Buy
- Analyst Count
- PED 1
- BRNS 1
- Target Price
- PED $1.50
- BRNS $3.00
- AVG Volume (30 Days)
- PED 223.2K
- BRNS 74.7K
- Earning Date
- PED 11-12-2025
- BRNS 11-06-2025
- Dividend Yield
- PED N/A
- BRNS N/A
- EPS Growth
- PED 569.41
- BRNS N/A
- EPS
- PED 0.14
- BRNS N/A
- Revenue
- PED $35,334,000.00
- BRNS $14,969,000.00
- Revenue This Year
- PED N/A
- BRNS N/A
- Revenue Next Year
- PED $17.41
- BRNS N/A
- P/E Ratio
- PED $4.62
- BRNS N/A
- Revenue Growth
- PED 3.93
- BRNS 1766.46
- 52 Week Low
- PED $0.47
- BRNS $0.64
- 52 Week High
- PED $1.00
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- PED 48.32
- BRNS 47.49
- Support Level
- PED $0.58
- BRNS $1.20
- Resistance Level
- PED $0.67
- BRNS $1.40
- Average True Range (ATR)
- PED 0.04
- BRNS 0.12
- MACD
- PED 0.01
- BRNS -0.02
- Stochastic Oscillator
- PED 28.60
- BRNS 30.00
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.